A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing–remitting multiple sclerosis

被引：0

作者：

C. Louapre

M. Rosenzwajg

M. Golse

A. Roux

F. Pitoiset

L. Adda

N. Tchitchek

C. Papeix

E. Maillart

A. Ungureanu

F. Charbonnier-Beaupel

D. Galanaud

J. C. Corvol

E. Vicaut

C. Lubetzki

D. Klatzmann

机构：

[1] Sorbonne University,Neuroradiology Department

[2] Paris Brain Institute - ICM,undefined

[3] Assistance Publique Hôpitaux de Paris,undefined

[4] Inserm,undefined

[5] CNRS,undefined

[6] Hôpital de la Pitié Salpêtrière,undefined

[7] Department of Neurology,undefined

[8] CIC neurosciences,undefined

[9] Immunology-Immunopathology-Immunotherapy (i3)-UMRS_959,undefined

[10] Sorbonne Université- INSERM,undefined

[11] Assistance Publique Hôpitaux de Paris,undefined

[12] Hôpital Pitié-Salpêtrière,undefined

[13] Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD),undefined

[14] Assistance Publique Hôpitaux de Paris,undefined

[15] Hôpital Pitié-Salpêtrière,undefined

[16] Pharmacie à Usage Intérieur,undefined

[17] Reqpharm Unit,undefined

[18] Sorbonne University,undefined

[19] Assistance Publique Hôpitaux de Paris,undefined

[20] Assistance Publique Hôpitaux de Paris,undefined

[21] Lariboisière Hospital,undefined

[22] Clinical Trial Unit,undefined

来源：

Journal of Neurology | 2023年 / 270卷

关键词：

Neuroinflammation; Neurodegeneration; Immunoregulation; Immunosuppression; Tolerance; Immunotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：4403 / 4414

页数：11

共 50 条

[21] A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis
Baumhackl, U
Kappos, L
Radue, EW
Freitag, P
Guseo, A
Daumer, M
Mertin, J
MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (02) : 166 - 168
[22] Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial
Shaygannejad, Vahid
Janghorbani, Mohsen
Ashtari, Fereshteh
Dehghan, Hamed
MULTIPLE SCLEROSIS INTERNATIONAL, 2012, 2012
[23] The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial
Katline Metzger-Peter
Laurent Daniel Kremer
Gilles Edan
Paulo Loureiro De Sousa
Julien Lamy
Dominique Bagnard
Ayikoe-Guy Mensah-Nyagan
Thibault Tricard
Guillaume Mathey
Marc Debouverie
Eric Berger
Anne Kerbrat
Nicolas Meyer
Jérôme De Seze
Nicolas Collongues
Trials, 21
[24] The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial
Metzger-Peter, Katline
Kremer, Laurent Daniel
Edan, Gilles
De Sousa, Paulo Loureiro
Lamy, Julien
Bagnard, Dominique
Mensah-Nyagan, Ayikoe-Guy
Tricard, Thibault
Mathey, Guillaume
Debouverie, Marc
Berger, Eric
Kerbrat, Anne
Meyer, Nicolas
De Seze, Jerome
Collongues, Nicolas
TRIALS, 2020, 21 (01)
[25] A MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF INTERLEUKIN-2 IN CHRONIC HEPATITIS-B
CARRENO, V
ARTILLO, S
BARTOLOME, J
PASTORE, G
SANTANTONIO, T
MILELLA, M
FATTOVICH, G
GIUSTINA, G
ALBERTI, A
CHANEAC, M
HEPATOLOGY, 1993, 18 (04) : A225 - A225
[26] Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial (vol 16, 901846, 2022)
Rahimlou, Mehran
Nematollahi, Shima
Husain, Durdana
Banaei-Jahromi, Nasrin
Majdinasab, Nastaran
Hosseini, Seyed Ahmad
FRONTIERS IN NEUROSCIENCE, 2022, 16
[27] Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis A Randomized, Placebo-Controlled Trial
Bellmann-Strobl, Judith
Paul, Friedemann
Wuerfel, Jens
Doerr, Jan
Infante-Duarte, Carmen
Heidrich, Elmira
Koertgen, Benedict
Brandt, Alexander
Pfuller, Caspar
Radbruch, Helena
Rust, Rebekka
Siffrin, Volker
Aktas, Orhan
Heesen, Christoph
Faiss, Juergen
Hoffmann, Frank
Lorenz, Mario
Zimmermann, Benno
Groppa, Sergiu
Wernecke, Klaus-Dieter
Zipp, Frauke
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (03):
[28] Efficacy of low-dose nebulized epinephrine as treatment for croup: A randomized, placebo-controlled, double-blind trial
Lee, Jin Hee
Jung, Jae Yun
Lee, Hyun Jung
Kim, Do Kyun
Kwak, Young Ho
Chang, Ikwan
Kwon, Hyuksool
Choi, Yoo Jin
Park, Joong Wan
Paek, So Hyun
Cho, Jun Hwi
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2019, 37 (12): : 2171 - 2176
[29] A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis
Miller, AE
Morgante, LA
Buchwald, LY
Coyle, PK
Krupp, LB
Doscher, CA
Lublin, FD
Knobler, RL
Trantas, F
Kelley, L
Smith, CR
LaRocca, N
Lopez, S
NEUROLOGY, 1997, 48 (02) : 312 - 314
[30] A randomised, double-blind, placebo-controlled study of fluoxetine for relapsing multiple sclerosis
Mostert, I. P.
Admilaal-Behlou, E.
Hoogduin, I. M.
Luyetidijk, J.
Heersema, D. J.
van Buchem, M. A.
de Keyser, J.
MULTIPLE SCLEROSIS, 2007, 13 : S25 - S26

← 1 2 3 4 5 →